When your company sells oncology infusion therapies to a PBM, you might assume a large portion will be used in the hospital setting.
Tag: cancer
Moving the Needle on Patient Satisfaction Without Adding to Physician Burnout
Patient satisfaction is more important than ever. But oncology care teams are already overwhelmed.
Oncology Practice Consolidation & Emerging Organizational Needs
Increases in oncology practice consolidation will require life science companies to re-evaluate their customer engagement strategies and provide newly integrated practices with tools to succeed.
Accelerating the Adoption and Diffusion of New Cancer Drugs
In today’s oncology landscape, a thoughtful and intentional approach is needed to minimize the length of time it takes to get new drugs into regular clinical use.
NCCN Policy Summit Speakers Say Flexibility in Supporting and Accommodating Cancer Patients and Caregivers Helps Workplaces Thrive
WASHINGTON, June 17, 2022 – The National Comprehensive Cancer Network® (NCCN®) convened an oncology policy summit in Washington D.C. today on the topic of building a workplace that includes support for people with cancer and their caregivers. The program, which also featured a virtual attendance option, examined how workplace norms and expectations have changed in recent years, particularly since the onset of the COVID-19 pandemic. The conversation also examined the current legal and policy landscape, plus how generational shifts and an increasing number of cancer survivors in the workforce are leading to cultural changes throughout the United States.
TKG and Oncology Executive Thought Leaders Discuss Technology and Process Innovations in Clinical Operations
NEW YORK, NY, May 21, 2021 – The Kinetix Group (TKG) assembled Oncology Thought Leaders from leading cancer centers and advocacy organizations from across the nation to virtually discuss insights and innovations in cancer care delivery amidst accelerating disruptive forces, given the challenges of the current COVID-19 pandemic. Participants included senior executives from 14 leading organizations including Johns Hopkins Medicine, Duke Health System, University Hospitals Seidman Cancer Center, Northwestern University, City of Hope, Moffitt Cancer Center, Fox Chase Cancer Center, The James Cancer Center at Ohio State University, the Patient Advocate Foundation, University of Vermont, Rush Health, and Jefferson Health.